Marsh & McLennan Companies, Inc. (MRSH) gains on deep earnings beat
Marsh & McLennan Companies, Inc. (MRSH) gains after a solid third-quarter beat on both EPS and revenue. The deep dive looks beyond the headline, covering consulting strength, risk growth, reinsurance softness, margin expansion, and management’s raised savings plan and 2026 outlook.
Marsh & McLennan Companies (MRSH) reported a strong third quarter, beating estimates on both earnings and revenue and sending shares up 4.8%. The company also raised its Thrive savings target to $600 million, signaling more room to invest in sales, technology, AI, and client growth while still guiding to another year of margin expansion and solid EPS growth.
Marsh & McLennan Companies, Inc. (MRSH) gains on earnings. Shares rose 4.80% to $186.96 in regular trading on Oct. 15, 2026, after third-quarter EPS of $2.03 and revenue of $6.86B topped estimates of $1.97 and $6.64B.
Key Takeaways
MRSH beat consensus on both measures, reporting EPS of $2.03 versus $1.97 and revenue of $6.86B versus $6.64B.
Consulting led the quarter, with revenue up 9% reported and 8% on an underlying basis. Management consulting grew 14% on an underlying basis.
Risk revenue rose 10% reported and 5% on an underlying basis, while reinsurance revenue fell 6% because of soft property pricing.
Management raised its Thrive savings target to $600M from $400M and plans to use the added capacity for sales, technology, AI, and client investments.
The 2026 outlook calls for underlying revenue growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth.
Analyst sentiment stayed measured. The consensus rating is Hold, KBW kept Market Perform while cutting its target to $202 from $203, and Morgan Stanley carries an Equal-Weight rating.
The third quarter delivered a clean top-line and earnings beat. Revenue increased 8% year over year to $6.86B, while underlying revenue growth reached 5%. Adjusted EPS rose 10% year over year to $2.03. The result extended MRSH's recent pattern of topping estimates, following EPS of $2.96 versus $2.90 in the second quarter and $3.29 versus $3.22 in the first quarter.
Quarterly revenue was lower than the $7.40B reported in Q2 and $7.60B in Q1, but it exceeded the $6.59B in Q4 2025 and $6.35B in Q3 2025. Net income was $0.81B, compared with $1.27B in Q2 and $1.15B in Q1. The comparison reflects the normal mix of seasonal contributions across the business, rather than a reversal in the revenue trend.
Risk and Insurance Services produced $4.2B of revenue, up 7% reported and 3% on an underlying basis. The segment generated $1B of adjusted operating income, up 4%, with a 24.6% adjusted operating margin. Within the segment, the Risk business was the main engine. Revenue reached $3.7B, up 10% reported and 5% underlying, despite declining insurance prices.
Reinsurance revenue fell 6% to $374M on both reported and underlying bases. The segment faced continued softness in property reinsurance rates and a difficult comparison with a strong prior-year quarter. CFO Mark Christopher McGivney also noted that the third quarter is small for reinsurance, which makes the reported decline less useful as a full-year gauge.
Consulting revenue rose 9% to $2.7B, including 8% underlying growth. Adjusted operating income increased 9% to $593M, producing a 22.1% adjusted operating margin. People and Investments revenue increased 6% to $1.7B, or 5% on an underlying basis. Health and benefits grew 5%, while Investments and Retirement rose 8%.
At the consolidated level, adjusted operating income rose 6% to $1.5B, and the adjusted operating margin was 22.7%. For the first nine months, adjusted operating income grew 7% to $6.1B, the adjusted operating margin reached 28.1%, and adjusted EPS increased 9% to $8.29. MRSH also repurchased $500M of stock during the quarter, bringing year-to-date repurchases to $2B.
Market Reaction and Analyst Response
MRSH shares gained 4.80% to $186.96 during the Oct. 15 regular session. Trading volume reached 2,824,927 shares, above the 2,538,246 average. The move gave investors a direct response to the earnings beat, the larger cost program, and management's steady full-year outlook.
The analyst backdrop remains restrained rather than euphoric. Consensus stands at Hold, with 22 Hold ratings, 10 Buy ratings, 1 Strong Buy, and 1 Sell. That balance matters because a strong quarterly print does not automatically reset the stock's valuation debate.
Keefe, Bruyette & Woods analyst Meyer Shields kept a Market Perform rating and lowered the price target to $202 from $203. Morgan Stanley previously cut its target to $180 from $200 while maintaining Equal-Weight. Evercore ISI also lowered its target to $234 from $236 and had identified persistent commercial pricing declines as a pressure point ahead of the results.
The split between the stock reaction and the ratings is typical of a mature financial-services compounder. The beat and buybacks support the near-term case, while lower insurance prices and a Hold-heavy consensus restrain the multiple expansion story.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
CEO John Quinlan Doyle framed the quarter within a broad shift in business risk. He described wars, geoeconomics, extreme weather, and AI as forces changing how clients operate. His central argument is that MRSH's mix of risk, strategy, people, and investments services gives it a useful position as companies build resilience.
We are clearly in a period of change and uncertainty in the world. This change is structural, not cyclical, and it is happening at pace and all at once. - John Quinlan Doyle, CEO, Earnings Call
That view also explains MRSH's emphasis on AI. Doyle said the company is already using AI in client relationships, operations, and daily work. He highlighted AI-enabled products, consulting on AI transformation, digital infrastructure, and higher productivity for producers and consultants. He also pointed to cyber exposure as a risk that requires responsible implementation.
We are increasing our Thrive savings target to $600 million. - John Quinlan Doyle, CEO, Earnings Call
The Thrive increase is the most important operational change in the quarter. MRSH originally targeted $400M of savings. The new $600M target includes opportunities from Business and Client Services and technology advances. Management plans to reinvest the savings in sales capacity, new capabilities, branding, and technology.
We had a strong third quarter that showed continued momentum in underlying revenue growth and double digit EPS growth, reflecting our strong position and great execution. - Mark Christopher McGivney, CFO, Earnings Call
McGivney's financial message was steady. He reported 5% underlying revenue growth, 6% growth in adjusted operating income, and a 22.7% adjusted operating margin. He also outlined the segment split: Risk grew 5% underlying, Reinsurance declined 6%, People and Investments grew 5%, and Management Consulting grew 14%.
Q3 is a small quarter for reinsurance. - Mark Christopher McGivney, CFO, Earnings Call
For the rest of 2026, Doyle maintained the outlook for underlying revenue growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth. He also tied that outlook to current market conditions and the company's execution of Thrive. The guidance gives MRSH a financial base while AI and digital infrastructure provide the longer-term growth narrative.
Bottom Line
MRSH delivered the combination investors want from a large broker: a revenue and EPS beat, solid underlying growth, buybacks, and a larger efficiency program. The main tension remains visible in reinsurance pricing and the Hold-heavy analyst consensus, but the $600M Thrive target and continued consulting demand strengthen the earnings case.
+Did Marsh & McLennan (MRSH) beat earnings in the third quarter?
Yes. Marsh & McLennan reported adjusted EPS of $2.03 versus the $1.97 consensus estimate, and revenue of $6.86 billion versus expectations of $6.64 billion.
+Why did MRSH stock rise after earnings?
MRSH shares rose 4.80% to $186.96 after the company delivered a clean earnings and revenue beat. Investors also reacted positively to management raising its Thrive savings target to $600 million and reaffirming a steady 2026 outlook.
+Which business segments drove Marsh & McLennan's Q3 growth?
Consulting was a standout, with revenue up 9% reported and 8% underlying, while management consulting grew 14% on an underlying basis. Risk revenue also rose 10% reported and 5% underlying, though reinsurance revenue fell 6% because of soft property pricing.
+What is management guiding for Marsh & McLennan in 2026?
Management expects underlying revenue growth similar to 2025, another year of margin expansion, and solid adjusted EPS growth. The company also said the higher savings target will fund more investment in sales, technology, AI, and client initiatives.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on MRSH?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
